Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute
March 3 (Reuters) – Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up…
March 3 (Reuters) – Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up…
By David Dolan TOKYO, March 3 (Reuters) – Toyota’s decision to further sweeten its bid for group company Toyota Industries…
By Byron Kaye, Joanna Plucinska and Rajesh Kumar Singh SYDNEY/LONDON/CHICAGO, March 3 (Reuters) – The airline and tourism industries scrambled…
March 3 (Reuters) – U.S. Commerce Secretary Howard Lutnick has agreed to testify before the House Oversight Committee over his…
By Polina Devitt LONDON, March 3 (Reuters) – Gold’s appeal as it draws support from the widening conflict in the…
By Pete Schroeder WASHINGTON, March 3 (Reuters) – The U.S. Treasury Department and bank regulators are eyeing a comprehensive review…
WASHINGTON, March 2 (Reuters) – The “big wave” is yet to come in the war with Iran, U.S. President Donald…
March 2 (Reuters) – Nasdaq has sought approval from the U.S. Securities and Exchange Commission to roll out prediction markets…
By Howard Schneider WASHINGTON, March 2 (Reuters) – A U.S. economy that has weathered a year of trade, immigration and…
By Dhara Ranasinghe and Hadeel Al Sayegh LONDON/ABU DHABI, Feb 28 (Reuters) – The United States and Israel launched strikes…